Fairmount Funds Management LLC, Director at Cogent Biosciences, Inc. (COGT), sold 3,500,000 shares at $36.40 ($127.4M) on 2026-01-22, disclosed to the SEC on 2026-01-22.
Open-market sale of $127.4M COGT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SYRE | SELL | 2026-06-23 | $399.7M | — | Filing → |
| VRDN | BUY | 2026-05-13 | $20.0M | — | Filing → |
| ZBIO | BUY | 2026-04-01 | $3.0M | — | Filing → |